SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Machine learning-guided analysis of metabolomic alterations in Parkinson's disease with comorbid symptoms.

Front Aging Neurosci · 2026-01-13

DOI: 10.3389/fnagi.2025.1753016PMID: 41607499

Open accessresearch-article; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

IntroductionAs a common neurodegenerative disorder, Parkinson's disease (PD) primarily affects dopaminergic neurons, leading to progressive motor disabilities along with a spectrum of non-motor complications. The early identification of Parkinson's disease, as well as the exploration of biomarkers related to its associated comorbidities, remains an important focus of current research.MethodsIn this study, a metabolomics approach combined with machine learning techniques was applied to explore potential biomarkers for PD and its related comorbid conditions. Using liquid chromatography-tandem mass spectrometry (LC-MS/MS), blood plasma samples were analyzed from individuals with PD, PD with rapid eye movement sleep behavior disorder (PD+RBD), PD with insomnia (PD + insomnia), and healthy controls, resulting in the detection of 2,601 metabolites. Multivariate statistical methods-including the unsupervised principal component analysis (PCA) and the supervised techniques of partial least squares discriminant analysis (PLS-DA) and orthogonal partial least squares discriminant analysis (OPLS-DA)-were employed to investigate intergroup metabolic variations. Machine learning algorithms, such as recursive feature elimination in conjunction with logistic regression, random forest, and support vector machines, were used to assist in selecting discriminative metabolites and constructing classification models.ResultsThese models showed strong internal performance in distinguishing PD from healthy individuals and in characterizing PD patients with non-motor comorbidities such as RBD and insomnia. Overall, the results suggest that metabolic biomarkers may provide valuable insights into disease-related and symptom-associated metabolic alterations in Parkinson's disease.DiscussionThis study provides a basis for future investigations aimed at validating these findings and further exploring their potential relevance in clinical research.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.